230
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone

, , &
Pages 2064-2075 | Received 01 Feb 2017, Accepted 03 Aug 2017, Published online: 10 Sep 2017

References

  • Kakran M, Li L, Muller RH. Overcoming the challenge of poor drug solubility. Pharm Eng. 2012;32:1–7.
  • Huang Y, Dai WG. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B. 2014;4:18–25.
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60:1281–1302.
  • Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I: a comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull. 1961;9:866–872.
  • Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131–144.
  • Al-Obaidi H, Ke P, Brocchini S, et al. Characterization and stability of ternary solid dispersions with PVP and PHPMA. Int J Pharm. 2011;419:20–27.
  • Rashid R, Kim DW, Din F, ud, et al. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym. 2015;130:26–31.
  • Wang X, Michoel A, Van den Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm. 2005;303:54–61.
  • Ofokansi KC, Kenechukwu FC, Ezugwu RO, et al. Improved dissolution and anti-inflammatory activity of ibuprofen-polyethylene glycol 8000 solid dispersion systems. Int J Pharm Investig. 2016;6:139–147.
  • Shamsuddin S, Fazil M, Ansari SH, et al. Development and evaluation of solid dispersion of spironolactone using fusion method. Int J Pharm Investig. 2016;6:63–68.
  • Madgulkar A, Bandivadekar M, Shid T, et al. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole. Drug Dev Ind Pharm. 2016;42:28–38.
  • Nikghalb LA, Singh G, Singh G, et al. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012;2:170–175.
  • Ghareeb MM, Abdulrasool AA, Hussein AA, et al. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech. 2009;10:1206–1215.
  • Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066.
  • Liu L, Wang X. Improved dissolution of oleanolic acid with ternary solid dispersions. AAPS PharmSciTech. 2007;8:113.
  • Zaki RM, Ali AA, Menshaw SFE, et al. Effect of binary and ternary solid dispersions prepared by fusion method on the dissolution of poorly water soluble diacerein. Int J Drug Deliv. 2013;5:99–109.
  • Janssens S, Nagels S, Novoa de Armas H, et al. Formulation and characterization of ternary solid dispersions made up of itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm. 2008;69:158–166.
  • Shin SC, Kim J. Physicochemical characterization of solid dispersion of furosemide with TPGS. Int J Pharm. 2003;251:79–84.
  • Luque Otero M, Martell Claros N. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. Clin Ther. 2005;27:166–173.
  • Jing J, Ren W, Chen X, et al. Determination and pharmacokinetics of manidipine in human plasma by HPLC/ESIMS. Biomed Chromatogr. 2007;21:836–840.
  • Chamsai B, Limmatvapirat S, Sungthongjeen S, et al. Improved stability of solid dispersions of manidipine with polyethylene glycol 4000/copovidone blends: application of ternary phase diagram. Drug Dev Ind Pharm. 2017;43:483–491.
  • Burapapadh K, Takeuchi H, Sriamornsak P. Novel pectin-based nanoparticles prepared from nanoemulsion templates for improving in vitro dissolution and in vivo absorption of poorly water-soluble drug. Eur J Pharm Biopharm. 2012;82:250–261.
  • Weerapol Y, Limmatvapirat S, Jansakul C, et al. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state. Eur J Pharm Biopharm. 2015;91:25–34.
  • Kubota Y, Umegaki K, Kagota S, et al. Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biol Pharm Bull. 2006;29:1756–1758.
  • Xie T, Taylor LS. Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer. Pharm Res. 2016;33:739–750.
  • Laitinen R, Priemel PA, Surwase S, et al., 2014. Theoretical considerations in developing amorphous solid dispersions. In: Shah N, Sandhu H, Choi DS, et al., editors. Amorphous solid dispersions: theory and practice. New York: Springer-Verlag. p. 35–90.
  • Six K, Verreck G, Peeters J, et al. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J Pharm Sci. 2004;93:124–131.
  • Todeschini V, Renato de Oliveira P, Bernardi LS, et al. Delapril and manidipine characterization and purity evaluation in raw material. J Therm Anal Calorim. 2014;115:2295–2301.
  • Vasa DM, Dalal N, Katz JM, et al. Physical characterization of drug: polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques. J Pharm Sci. 2014;103:2911–2923.
  • Papadimitriou SA, Barmpalexis P, Karavas E, et al. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I. Eur J Pharm Biopharm. 2012;82:175–186.
  • Bikiaris D, Papageorgiou GZ, Stergiou A, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta. 2005;439:58–67.
  • Rao DR, Kanken RN, Ghagare MG. 2012. US Patent No. US2012/0232091A1. US Patent and Trademark Office.
  • Gumaste SG, Gupta SS, Serajuddin ATM. Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion. AAPS J. 2016;18:1131–1143.
  • Chen WL, Guo DW, Shen YY, et al. Effects of highly hygroscopic excipients on the hydrolysis of simvastatin in tablet at high relative humidity. Indian J Pharm Sci. 2012;74:527–534.
  • Kothari K, Ragoonanan V, Suryanarayanan R. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions. Mol Pharm. 2015;12:162–170.
  • Guo Y, Luo J, Tan S, et al. The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175–186.
  • Lang B, Liu S, McGinity JW, et al. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions. Drug Dev Ind Pharm. 2016;42:429–445.
  • Truong DH, Tran TH, Ramasamy T, et al. Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib. AAPS PharmSciTech. 2016;17:466–473.
  • Gupta MK, Bogner RH, Goldman D, et al. Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage. Pharm Dev Technol. 2002;7:103–112.
  • Matsunaga N, Nakamura K, Yamamoto A, et al. Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEGF receptor-2 tyrosine kinase, and identification of its potential therapeutic window. Mol Cancer Ther. 2006;5:80–88.
  • Six K, Daems T, Hoon JD, et al. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci. 2005;24:179–186.
  • Cheer SM, McClellan K. Manidipine: a review of its use in hypertension. Drugs. 2001;61:1777–1799.
  • Geleta B, Makonnen E, Debella A, et al. In vivo antihypertensive and antihyperlipidemic effects of the crude extracts and fractions of Moringa stenopetala (Baker f.) Cufod. leaves in rats. Front Pharmacol. 2016;7:97.
  • Frishman WH. Calcium channel blockers: differences between subclasses. Am J Cardiovasc Drugs. 2007;7(Suppl 1):17–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.